PDF
TB-7300-K2-BUND2
For Research Use Only.
Not for use in diagnostic procedures.

QuickSwitch™ Quant HLA-A*02:01-APC and Peptides Bundle 2

Code No.
TB-7300-K2-BUND2
Quantity
NA
PDF

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Target: Chain A, SARS-CoV-2 spike glycoprotein (1060-1068), Chain A, SARS-CoV-2 spike glycoprotein (424-433), Chain A, SARS-CoV-2 spike glycoprotein (691-699), ORF1ab polyprotein SARS-CoV-2 (5583-5591), SARS-CoV-2 ORF3a protein (107-115), SARS-CoV-2 Spike Glycoprotein

Product Type: Peptide, Tetramer

Application: FCM

Class: Class I

Species Reactivity: Human

Peptide Sequence: ISDEFSSNV, KLPDDFTGCV, RLNEVAKNL, RLQSLQTYV, SIIAYTMSL, VVFLHVTYV, YLQPRTFLL, YLYALVYFL

Research Area: Immunology, Immune Monitoring

Protocols: FCM

Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.

QuickSwitch™ Quant HLA-A*02:01-APC and Peptides Bundle 2

Related Product

TB-0029-4 HLA-A*02:01 Negative Tetramer-BV421
TB-0029-2 iTAg HLA-A*02:01 Negative Tetramer- APC
TB-0029-1 iTAg HLA-A*02:01 Negative Tetramer-PE
SP0029 Peptide HLA-A*02:01 Human Negative control 1 mg (formerly code #TS-0029-P)
* For the most up to date product information and protocols, please visit mblintl.com
For Research Use Only, Not for use in diagnostic procedures
A JSR Life Sciences Company
MBL International 15A Constitution Way Woburn, MA 01801
https://products.mblintl.com/products/tb-7300-k2-bund2/